In addition, NEIL3 partially induced the activation of the PI3K/Akt/mTOR signaling pathway in HCC, but the authors did not investigate in depth whether NEIL3 promotes HCC progression through activation of this pathway [66] (Figure 3). Here, MTOR is linked to hepatocellular carcinoma.